Last week, The University of Liverpool hosted the first official gathering of the global partners from the Centres for Antimicrobial Optimisation Network (CAMO-Net) for a welcome reception and the inaugural CAMO-Net Management Board Meeting.
The welcome reception in Liverpool gave the opportunity for researchers to highlight projects and innovations already taking place within Liverpool and London, whilst also providing the chance to network and share knowledge. The scope of activities and discussion focused on innovation in technology and data usage at the molecular, patient, drug and health sector level, through to the whole population level.
Before exploring exhibitions from researchers based in Liverpool and London, attendees heard from Professor Louise Kenny, Executive Pro Vice Chancellor of the Faculty of Health and Life Sciences at the University of Liverpool,. Professor Kenny highlighted antimicrobial resistance (AMR) as one of the greatest threats to the health of communities around the world, and how timely the CAMO-Net collaboration is in tackling this important challenge.
Professor Kenny said: “Global threats require a global partnership and so we are delighted that nationally here in the UK CAMO-Net has strengthened a long-standing strategic alliance with Imperial College London and that our two institutions are part of this wonderful global network of interdisciplinary experts, who will ensure that lifesaving drugs are preserved for future generations.”
CAMO-Net will use its extensive network of interdisciplinary experts, partners at the forefront of relevant technological innovation and links with policymakers to conduct research to actionably improve antimicrobial use in humans through three interlinked themes identified through a Wellcome-commissioned roadmap.
Chibuzor Uchea, Research Manager of Drug Resistant Infections at the Wellcome Trust also addressed the event, and highlighted the vital work of the project. He said, ““The inappropriate human use of antimicrobials is a key driver of AMR and importantly the driver most under our direct control. Supporting research into the optimal use of antimicrobials is vital to preserve and sustain their efficacy. CAMO-Net has huge potential for creating significant and lasting impact in the AMR field.”
Professor Alison Holmes OBE, Principal Investigator for CAMO-Net UK, hosted the event. Professor Holmes commented: “Not only will this network provide a unique opportunity to advance multidisciplinary research to improve and sustain access to effective antimicrobial treatments and address AMR, it has shared international learning embedded within it and also represents a major commitment to more equitable research models.”
